了解DBS:患者对帕金森病深层大脑刺激的感知和知识
Meagen Salinas1,2, Umar Yazdani3, Austin Oblack3
1Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
Therapeutic advances in neurological disorders
|March 8, 2024
概括
对于帕金森病 (PD) 的深度大脑刺激 (DBS) 患者的感知受到年龄,疾病持续时间和教育的影响. 了解这些因素是改善DBS治疗患者咨询和治疗结果的关键.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 患者报告的结果
背景情况:
- 深度大脑刺激 (DBS) 是一种公认的帕金森病 (PD) 治疗方法,可以改善运动功能和生活质量.
- 然而,患者对DBS治疗的看法和理解仍未得到充分研究.
研究的目的:
- 评估患者对PDDBS的看法,重点关注理解,满意度和影响因素.
- 确定患者前景的关键决定因素,以提高DBS治疗的教育策略和咨询.
主要方法:
- 一项调查对77名帕金森病患者进行,这些患者在多个中心接受了DBS治疗.
- 调查问卷涵盖了人口统计,病史,对DBS指示的理解,副作用以及常见的误解.
- 用描述性统计和回归方法分析数据,以建模变量之间的关系.
主要成果:
- 参与者的平均年龄为66岁,主要是男性 (66%) 和白人 (90%),具有高学历 (79%的大学毕业生).
- 患者表现出对DBS对运动和非运动症状以及相关副作用的良好理解.
- 回归分析显示,年龄,疾病持续时间和教育水平显著影响了患者对DBS的理解和前景.
结论:
- 这项研究提供了对患者对PDDBS的看法的见解,突出了好处,挑战和误解.
- 调查结果强调需要解决患者知识和感知的差异,通过量身定制的咨询来优化DBS治疗结果.
更多相关视频
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.3K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.9K
相关概念视频
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:15Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544